Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_016489.12(NT5C3A):c.743_744insGG (p.Val249Glufs) | 51251 | NT5C3A | Pathogenic | 397518436 | RCV000004739; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33055330 | 33055331 | NM_016489.12:c.743_744insGG | NP_057573.2:p.Val249Glufs | NC_000007.13:g.33055330_33055331insCC | OMIM Allelic Variant:606224.0004 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_001002010.2(NT5C3A):c.838G>C (p.Gly280Arg) | 51251 | NT5C3A | Pathogenic | 104894029 | RCV000004745; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33055353 | 33055353 | NM_001002010.2:c.838G>C | NP_001002010.1:p.Gly280Arg | NC_000007.13:g.33055353C>G | OMIM Allelic Variant:606224.0010 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_016489.12(NT5C3A):c.592-1G>T | 51251 | NT5C3A | Pathogenic | 397518435 | RCV000004738; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33055483 | 33055483 | NM_016489.12:c.592-1G>T | | NC_000007.13:g.33055483C>A,NC_000007.13:g.33055483C>G | OMIM Allelic Variant:606224.0003 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_016489.12(NT5C3A):c.592-1G>C | 51251 | NT5C3A | Pathogenic | 397518435 | RCV000004742; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33055483 | 33055483 | NM_016489.12:c.592-1G>C | | NC_000007.13:g.33055483C>A,NC_000007.13:g.33055483C>G | OMIM Allelic Variant:606224.0007 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_016489.12(NT5C3A):c.576delG (p.Asp193Ilefs) | 51251 | NT5C3A | Pathogenic | 397518438 | RCV000004744; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33057066 | 33057066 | NM_016489.12:c.576delG | NP_057573.2:p.Asp193Ilefs | NC_000007.13:g.33057066delC | OMIM Allelic Variant:606224.0009 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_001002010.2(NT5C3A):c.686A>G (p.Asn229Ser) | 51251 | NT5C3A | Pathogenic | 104894028 | RCV000004743; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33057073 | 33057073 | NM_001002010.2:c.686A>G | NP_001002010.1:p.Asn229Ser | NC_000007.13:g.33057073T>C | OMIM Allelic Variant:606224.0008 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_001002010.2(NT5C3A):c.660T>G (p.Tyr220Ter) | 51251 | NT5C3A | Pathogenic | 104894027 | RCV000004740; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33057099 | 33057099 | NM_001002010.2:c.660T>G | NP_001002010.1:p.Tyr220Ter | NC_000007.13:g.33057099A>C | OMIM Allelic Variant:606224.0005 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_001002010.2(NT5C3A):c.646C>T (p.Gln216Ter) | 51251 | NT5C3A | Pathogenic | 104894026 | RCV000004737; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33057113 | 33057113 | NM_001002010.2:c.646C>T | NP_001002010.1:p.Gln216Ter | NC_000007.13:g.33057113G>A | OMIM Allelic Variant:606224.0002 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_016489.12(NT5C3A):c.384dupA (p.Ala129Serfs) | 51251 | NT5C3A | Pathogenic | 397518437 | RCV000004741; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33059291 | 33059291 | NM_016489.12:c.384dupA | NP_057573.2:p.Ala129Serfs | NC_000007.13:g.33059291dupT | OMIM Allelic Variant:606224.0006 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |
NM_001002010.2(NT5C3A):c.410A>T (p.Asp137Val) | 51251 | NT5C3A | Pathogenic | 104894025 | RCV000004736; | N | MedGen:C1849507,OMIM:266120,ORPHA:35120 | 7 | 33060929 | 33060929 | NM_001002010.2:c.410A>T | NP_001002010.1:p.Asp137Val | NC_000007.13:g.33060929T>A | OMIM Allelic Variant:606224.0001 | C1849507 266120 Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to | | |